<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35198136</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2040-6223</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Therapeutic advances in chronic disease</Title><ISOAbbreviation>Ther Adv Chronic Dis</ISOAbbreviation></Journal><ArticleTitle>Neurological manifestations of long-COVID syndrome: a narrative review.</ArticleTitle><Pagination><StartPage>20406223221076890</StartPage><MedlinePgn>20406223221076890</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20406223221076890</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/20406223221076890</ELocationID><Abstract><AbstractText>Accumulating evidence points toward a very high prevalence of prolonged neurological symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no solidified criteria for 'long-COVID' diagnosis. Nevertheless, 'long-COVID' is conceptualized as a multi-organ disorder with a wide spectrum of clinical manifestations that may be indicative of underlying pulmonary, cardiovascular, endocrine, hematologic, renal, gastrointestinal, dermatologic, immunological, psychiatric, or neurological disease. Involvement of the central or peripheral nervous system is noted in more than one-third of patients with antecedent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, while an approximately threefold higher incidence of neurological symptoms is recorded in observational studies including patient-reported data. The most frequent neurological manifestations of 'long-COVID' encompass fatigue; 'brain fog'; headache; cognitive impairment; sleep, mood, smell, or taste disorders; myalgias; sensorimotor deficits; and dysautonomia. Although very limited evidence exists to date on the pathophysiological mechanisms implicated in the manifestation of 'long-COVID', neuroinflammatory and oxidative stress processes are thought to prevail in propagating neurological 'long-COVID' sequelae. In this narrative review, we sought to present a comprehensive overview of our current understanding of clinical features, risk factors, and pathophysiological processes of neurological 'long-COVID' sequelae. Moreover, we propose diagnostic and therapeutic algorithms that may aid in the prompt recognition and management of underlying causes of neurological symptoms that persist beyond the resolution of acute COVID-19. Furthermore, as causal treatments for 'long-COVID' are currently unavailable, we propose therapeutic approaches for symptom-oriented management of neurological 'long-COVID' symptoms. In addition, we emphasize that collaborative research initiatives are urgently needed to expedite the development of preventive and therapeutic strategies for neurological 'long-COVID' sequelae.</AbstractText><CopyrightInformation>&#xa9; The Author(s), 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stefanou</LastName><ForeName>Maria-Ioanna</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palaiodimou</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakola</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smyrnis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Second Department of Psychiatry, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadopoulou</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece; Department of Physiotherapy, University of West Attica, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paraskevas</LastName><ForeName>George P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizos</LastName><ForeName>Emmanouil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Second Department of Psychiatry, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutati</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Second Propaedeutic Department of Internal Medicine and Research Institute, University General Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grigoriadis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Second Department of Neurology, 'AHEPA' University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krogias</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital Bochum, Ruhr University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Sotirios</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsiodras</LastName><ForeName>Sotirios</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>4th Department of Internal Medicine, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaga</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>7th Respiratory Medicine Department and Asthma Center, Athens Chest Hospital 'Sotiria', Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsivgoulis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0640-3797</Identifier><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Rimini 1, Chaidari, 12462 Athens, Greece. Department of Neurology, The University of Tennessee Health Science Center, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ther Adv Chronic Dis</MedlineTA><NlmUniqueID>101532140</NlmUniqueID><ISSNLinking>2040-6223</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">long-haul</Keyword><Keyword MajorTopicYN="N">neurological manifestations</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2</Keyword></KeywordList><CoiStatement>Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35198136</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pii">10.1177_20406223221076890</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nicola M, Alsafi Z, Sohrabi C, et al.. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg 2020; 78: 185&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162753</ArticleId><ArticleId IdType="pubmed">32305533</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med 2021; 27: 28&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long COVID. BMJ 2020; 371: m4938.</Citation><ArticleIdList><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med 2021; 268: 113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, et al.. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw Open 2021; 4: e2127403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, et al.. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health 2021; 18: 2621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis 2021; 53: 737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, et al.. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021; 372: n136.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S, Williams MA. Confronting our next national health disaster &#x2013; Long-Haul Covid. N Engl J Med 2021; 385: 577&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-Haul COVID. Neurology 2020; 95: 559&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al.. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6: 100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B, Seang S, Tubiana R, et al.. Post-COVID-19 chronic symptoms: a postinfectious entity. Clin Microbiol Infect 2020; 26: 1448&#x2013;1449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al.. Post-acute COVID-19 syndrome. Nat Med 2021; 27: 601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh ES, Vannorsdall TD, Parker AM. Post-acute sequelae of SARS-CoV-2 infection and subjective memory problems. JAMA Netw Open 2021; 4: e2119335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9170372</ArticleId><ArticleId IdType="pubmed">34323990</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossman H, Shilo S, Meir T, et al.. COVID-19 dynamics after a national immunization program in Israel. Nat Med 2021; 27: 1055&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">33875890</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritchard E, Matthews PC, Stoesser N, et al.. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nat Med 2021; 27: 1370&#x2013;1378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363500</ArticleId><ArticleId IdType="pubmed">34108716</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control Prevention (CDC).
Post-COVID conditions: information for healthcare providers, 2021, https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html</Citation></Reference><Reference><Citation>
World Health Organization (WHO). A clinical case definition of post COVID-19 condition by a Delphi consensus, 6
October
2021, 2021, https://www.who.int/docs/default-source/coronaviruse/corrigendum-2021.1-post-covid-19-clinical-case-definition-2021-10-06-corr-2021-10-06-en.pdf?sfvrsn=1ebb697c_5</Citation></Reference><Reference><Citation>
National Institute for Health Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19, 2020, https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization (WHO). Emergency use ICD codes for COVID-19 disease outbreak, 2020, https://www.who.int/standards/classifications/classification-of-diseases/emergency-use-icd-codes-for-covid-19-disease-outbreak</Citation></Reference><Reference><Citation>Moghimi N, Di Napoli M, Biller J, et al.. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep 2021; 21: 44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G, Palaiodimou L, Katsanos AH, et al.. Neurological manifestations and implications of COVID-19 pandemic. Ther Adv Neurol Disord 2020; 13: 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7284455</ArticleId><ArticleId IdType="pubmed">32565914</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G, Palaiodimou L, Zand R, et al.. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord 2020; 13: 1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727052</ArticleId><ArticleId IdType="pubmed">33343709</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimou L, Stefanou MI, Katsanos AH, et al.. Prevalence, clinical characteristics and outcomes of Guillain-Barr&#xe9; syndrome spectrum associated with COVID-19: a systematic review and meta-analysis. Eur J Neurol 2021; 28: 3517&#x2013;3529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250909</ArticleId><ArticleId IdType="pubmed">33837630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri RM, Campenn&#xec; A, Deandreis D, et al.. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol 2021; 17: 737&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8182818</ArticleId><ArticleId IdType="pubmed">34015983</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institutes of Health (NIH). NIH launches new initiative to study &#x2018;Long COVID&#x2019;, 2021, https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid</Citation></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, et al.. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021; 8: 416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Allot A, Lu Z. LitCovid: an open database of COVID-19 literature. Nucleic Acids Res 2021; 49: D1534&#x2013;D1540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778958</ArticleId><ArticleId IdType="pubmed">33166392</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, et al.. Long covid &#x2013; mechanisms, risk factors, and management. BMJ 2021; 374: n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Counting the neurological cost of COVID-19. Nat Rev Neurol 2021: 1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600497</ArticleId><ArticleId IdType="pubmed">34795449</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SH, Beghi E, Helbok R, et al.. Global incidence of neurological manifestations among patients hospitalized with COVID-19-A report for the GCS-NeuroCOVID consortium and the energy consortium. JAMA Netw Open 2021; 4: e2112131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M, Go&#xeb;rtz YMJ, Houben-Wilke S, et al.. Severe fatigue in Long COVID: web-based quantitative follow-up study in members of online long COVID support groups. J Med Internet Res 2021; 23: e30274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8457337</ArticleId><ArticleId IdType="pubmed">34494964</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al.. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 2021; 4: e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Beckers E, et al.. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med 2021; 290: 451&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">33403772</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al.. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2021; 76: 396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrahi A, Ahluwalia M, Khodadadi H, et al.. Neurological consequences of COVID-19: what have we learned and where do we go from here? J Neuroinflammation 2020; 17: 286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7525232</ArticleId><ArticleId IdType="pubmed">32998763</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Cristillo V, Cotti Piccinelli S, et al.. Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci 2021; 42: 4903&#x2013;4907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al.. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11: 16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G, Fragkou PC, Lachanis S, et al.. Olfactory bulb and mucosa abnormalities in persistent COVID-19-induced anosmia: a magnetic resonance imaging study. Eur J Neurol 2021; 28: e6&#x2013;e8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32939911</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G, Fragkou PC, Karofylakis E, et al.. Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study. J Neurol Neurosurg Psychiatry 2021; 92: 911&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pubmed">33879534</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsatsakis A, Calina D, Falzone L, et al.. SARS-CoV-2 pathophysiology and its clinical implications: an integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020; 146: 111769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833750</ArticleId><ArticleId IdType="pubmed">32979398</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulfamante G, Bocci T, Falleni M, et al.. Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung. J Neurol 2021; 268: 4486&#x2013;4491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129960</ArticleId><ArticleId IdType="pubmed">34003372</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, McAlpine LS, Gardin T, et al.. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol 2020; 77: 1018&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhang Y, Wu L, et al.. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 2020; 181: 894&#x2013;904.e899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144619</ArticleId><ArticleId IdType="pubmed">32275855</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et al.. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19: 919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennisi M, Lanza G, Falzone L, et al.. SARS-CoV-2 and the nervous system: from clinical features to molecular mechanisms. Int J Mol Sci 2020; 21: 5475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7432482</ArticleId><ArticleId IdType="pubmed">32751841</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcom EF, Nath A, Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain 2021; 144: 3576&#x2013;3588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Fu L, Gonzales DM, et al.. Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J Virol 2004; 78: 3398&#x2013;3406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC371061</ArticleId><ArticleId IdType="pubmed">15016862</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A, Frontera J, Placantonakis DG, et al.. Cerebrospinal fluid in COVID-19: a systematic review of the literature. J Neurol Sci 2021; 421: 117316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833669</ArticleId><ArticleId IdType="pubmed">33561753</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Normandin E, Bhattacharyya S, et al.. Neuropathological features of Covid-19. N Engl J Med 2020; 383: 989&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Schneider J, Greuel S, et al.. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol 2021; 78: 948&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, et al.. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol 2021; 12: 686029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Deleterious outcomes in Long-Hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci 2020; 11: 4017&#x2013;4020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw WJ, Pogue A, Hill JM. SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol 2020; 42: 217&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Wang K, Yu J, et al.. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 2020; 11: 573095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G, Schroeter N, Bormann T, et al.. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med 2021; 62: 910&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, et al.. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging 2021; 48: 2823&#x2013;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, et al.. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res 2021; 31: 365&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, St&#xe5;hlberg M, Runold M, et al.. Long-Haul Post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep 2021; 3: 573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenney JR, Rozhkov L, Horn P, et al.. Cerebral glucose hypometabolism is associated with mitochondrial dysfunction in patients with intractable epilepsy and cortical dysplasia. Epilepsia 2014; 55: 1415&#x2013;1422.</Citation><ArticleIdList><ArticleId IdType="pubmed">25053176</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekar LK, Wei HS, Nedergaard M. The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand. J Cereb Blood Flow Metab 2012; 32: 2135&#x2013;2145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3519408</ArticleId><ArticleId IdType="pubmed">22872230</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, H&#xe4;llqvist J, Gilmour KC, et al.. &#x2018;The long tail of Covid-19&#x2019; &#x2013; The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res 2020; 99: 1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N, Le Guen M, Russel S, et al.. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep 2021; 11: 14042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshak N, Abdelnabi M, Ball S, et al.. Dysautonomia: an overlooked neurological manifestation in a critically ill COVID-19 patient. Am J Med Sci 2020; 360: 427&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366085</ArticleId><ArticleId IdType="pubmed">32739039</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyagi Y, Ohashi M, Funahashi R, et al.. Oropharyngeal dysphagia and aspiration pneumonia following coronavirus disease 2019: a case report. Dysphagia 2020; 35: 545&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290133</ArticleId><ArticleId IdType="pubmed">32533346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli SG, Altundag A, Yildirim D, et al.. Olfactory Bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Acad Radiol 2021; 28: 28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571972</ArticleId><ArticleId IdType="pubmed">33132007</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, et al.. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep 2021; 36: 109518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Naughton A, et al.. Longitudinal analysis of COVID-19 patients shows age-associated T cell changes independent of ongoing ill-health. Front Immunol 2021; 12: 676932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8138306</ArticleId><ArticleId IdType="pubmed">34025675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, et al.. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 2021; 4: 100100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>
Visvabharathy L, Hanson B, Orban Z, et al.. Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination. medRxiv, 2021, https://www.medrxiv.org/content/10.1101/2021.08.08.21261763v1.full</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.08.21261763v1.full</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Ciccarelli M, Cecconi M, et al.. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging 2021; 48: 1460&#x2013;1466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambadiari V, Mitrakou A, Kountouri A, et al.. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection. Eur J Heart Fail 2021; 23: 1916&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426810</ArticleId><ArticleId IdType="pubmed">34415085</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al.. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5: 1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et al.. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology 2021; 27: 328&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Zheng X-S, Shen X-R, et al.. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19. Emerg Microb Infect 2020; 9: 2571&#x2013;2577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734137</ArticleId><ArticleId IdType="pubmed">33196399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L, et al.. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020; 5: 434&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JC, et al.. Evolution of antibody immunity to SARS-CoV-2. Nature 2021; 591: 639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Quigley EMM. Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep 2017; 17: 94.</Citation><ArticleIdList><ArticleId IdType="pubmed">29039142</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Simr&#xe9;n J, Ed&#xe9;n A, et al.. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. Ebiomedicine 2021; 70: 103512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, et al.. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 2021; 595: 565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al.. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2013; United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T, Kuroda N. Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: a systematic review. Clin Neurol Neurosurg 2021; 200: 106349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604080</ArticleId><ArticleId IdType="pubmed">33172719</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al.. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2013; United States, March&#x2013;June 2020. Morb Mortal Wkly Rep 2020; 69: 993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight MA, Court C, et al.. Management of post-acute covid-19 in primary care. BMJ 2020; 370: m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanfi SH, Lalani TK, Saghir A, et al.. COVID-19 and its mimics: what the radiologist needs to know. J Thorac Imaging 2021; 36: W1&#x2013;W10.</Citation><ArticleIdList><ArticleId IdType="pubmed">32852419</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickel CH, Bingisser R. Mimics and chameleons of COVID-19. Swiss Med Wkly 2020; 150: w20231.</Citation><ArticleIdList><ArticleId IdType="pubmed">32202647</ArticleId></ArticleIdList></Reference><Reference><Citation>Sis&#xf3;-Almirall A, Brito-Zer&#xf3;n P, Conangla Ferr&#xed;n L, et al.. Long Covid-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health 2021; 18: 4350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Cardona M, Bell K, et al.. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. J Ass Med Microb Infect Dis Canada 2020; 5: 223&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9602871</ArticleId><ArticleId IdType="pubmed">36340059</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Guo Y, Mao R, et al.. Proportion of asymptomatic coronavirus disease 2019: a systematic review and meta-analysis. J Med Virol 2021; 93: 820&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404334</ArticleId><ArticleId IdType="pubmed">32691881</ArticleId></ArticleIdList></Reference><Reference><Citation>Poll&#xe1;n M, P&#xe9;rez-G&#xf3;mez B, Pastor-Barriuso R, et al.. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet 2020; 396: 535&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336131</ArticleId><ArticleId IdType="pubmed">32645347</ArticleId></ArticleIdList></Reference><Reference><Citation>Fill Malfertheiner S, Brandstetter S, Roth S, et al.. Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: a prospective longitudinal study. J Clin Virol 2020; 130: 104575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406471</ArticleId><ArticleId IdType="pubmed">32805631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Yuan Q, Wang H, et al.. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis 2020; 71: 2027&#x2013;2034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184337</ArticleId><ArticleId IdType="pubmed">32221519</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F, Srivastava K, Alshammary H, et al.. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med 2021; 384: 1372&#x2013;1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008743</ArticleId><ArticleId IdType="pubmed">33691060</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatatos L, Czartoski J, Wan YH, et al.. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science 2021; 372: 1413&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8139425</ArticleId><ArticleId IdType="pubmed">33766944</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, et al.. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med 2021; 174: 1252&#x2013;1260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, et al.. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021; 76: 399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker AJ, Humbir A, Tiwary P, et al.. Recovery after critical illness in COVID-19 ICU survivors. Br J Anaesth 2021; 126: e217&#x2013;e219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7972647</ArticleId><ArticleId IdType="pubmed">33812669</ArticleId></ArticleIdList></Reference><Reference><Citation>Stam HJ, Stucki G, Bickenbach J. Covid-19 and post intensive care syndrome: a call for action. J Rehabil Med 2020; 52: jrm00044.</Citation><ArticleIdList><ArticleId IdType="pubmed">32286675</ArticleId></ArticleIdList></Reference><Reference><Citation>Caba&#xf1;es-Mart&#xed;nez L, Villad&#xf3;niga M, Gonz&#xe1;lez-Rodr&#xed;guez L, et al.. Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol 2020; 131: 2809&#x2013;2816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7558229</ArticleId><ArticleId IdType="pubmed">33137571</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S, Xiao M, Han F, et al.. Neurological manifestations in critically ill patients with COVID-19: a retrospective study. Front Neurol 2020; 11: 806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365850</ArticleId><ArticleId IdType="pubmed">32754114</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlit P, B&#xf6;sel J, Gahn G, et al.. &#x2018;Neurological manifestations of COVID-19&#x2019; &#x2013; guideline of the German society of neurology. Neurol Res Pract 2020; 2: 51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7708894</ArticleId><ArticleId IdType="pubmed">33283160</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding H, Yin S, Cheng Y, et al.. Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China. Medcomm 2020; 1: 253&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362024</ArticleId><ArticleId IdType="pubmed">34172986</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al.. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome. ERJ Open Res 2020; 6: 00542-2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawal G, Yadav S, Kumar R. Post-intensive care syndrome: an overview. J Transl Inter Med 2017; 5: 90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506407</ArticleId><ArticleId IdType="pubmed">28721340</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, et al.. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine 2021; 36: 100899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al.. Attributes and predictors of long COVID. Nat Med 2021; 27: 626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al.. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2021; 27: 258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, et al.. Preliminary evidence on long COVID in children. Acta Paediatr 2021; 110: 2208&#x2013;2211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>
Castro VM, Gunning FM, Perlis RH.
Persistence of neuropsychiatric symptoms associated with SARS-CoV-2 positivity among a cohort of children and adolescents. medRxiv, 2021, https://www.medrxiv.org/content/10.1101/2021.09.28.21264259v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.09.28.21264259v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahidy FS, Pan AP, Ahnstedt H, et al.. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS ONE 2021; 16: e0245556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7806140</ArticleId><ArticleId IdType="pubmed">33439908</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivonello R, Auriemma RS, Pivonello C, et al.. Sex disparities in COVID-19 severity and outcome: are men weaker or women stronger? Neuroendocrinology 2021; 111: 1066&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7900484</ArticleId><ArticleId IdType="pubmed">33242856</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi T, Hu T, Ge QQ, et al.. COVID-19 pandemic related long-term chronic stress on the prevalence of depression and anxiety in the general population. BMC Psychiatry 2021; 21: 380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8316891</ArticleId><ArticleId IdType="pubmed">34320924</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud M, Thibault C, Le Normand F, et al.. Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis. JAMA Netw Open 2021; 4: e2115352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226421</ArticleId><ArticleId IdType="pubmed">34165581</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al.. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021; 398: 747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Latronico N, Peli E, Calza S, et al.. Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS. Thorax. Epub ahead of print 29 September 2021. DOI: 10.1136/thoraxjnl-2021-218064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218064.</ArticleId><ArticleId IdType="pubmed">34588274</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Neurology. Long COVID: understanding the neurological effects. Lancet Neurol 2021; 20: 247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7969137</ArticleId><ArticleId IdType="pubmed">33743226</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovere Querini P, De Lorenzo R, Conte C, et al.. Post-COVID-19 follow-up clinic: depicting chronicity of a new disease. Acta Biomed 2020; 91: 22&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023087</ArticleId><ArticleId IdType="pubmed">32701913</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto M, Gimigliano F, De Simone S, et al.. Post-acute COVID-19 rehabilitation network proposal: from intensive to extensive and home-based IT supported services. Int J Environ Res Public Health 2020; 17: 9335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764833</ArticleId><ArticleId IdType="pubmed">33327384</ArticleId></ArticleIdList></Reference><Reference><Citation>
British Thoracic Society. British Thoracic Society guidance on respiratory follow up of patients with a clinico-radiological diagnosis of COVID-19 pneumonia, 2020, https://www.brit-thoracic.org.uk/document-library/quality-improvement/COVID-19/resp-follow-up-guidance-post-COVID-pneumonia</Citation></Reference><Reference><Citation>Turner-Stokes L, Thu A, Williams H, et al.. The Neurological Impairment Scale: reliability and validity as a predictor of functional outcome in neurorehabilitation. Disabil Rehabil 2014; 36: 23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906250</ArticleId><ArticleId IdType="pubmed">23721497</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouby C, Thomas-Danguin T, Vigouroux M, et al.. The lyon clinical olfactory test: validation and measurement of hyposmia and anosmia in healthy and diseased populations. Int J Otolaryngol 2011; 2011: 203805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3199207</ArticleId><ArticleId IdType="pubmed">22046188</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounti F, Tsolaki M, Kiosseoglou G. Functional Cognitive Assessment Scale (FUCAS): a new scale to assess executive cognitive function in daily life activities in patients with dementia and mild cognitive impairment. Hum Psychopharmacol 2006; 21: 305&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">16856217</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Barker-Davies RM, O&#x2019;Sullivan O, Senaratne KPP, et al.. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020; 54: 949&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman A, Tabassum T, Araf Y, et al.. Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mol Biol Rep 2021; 48: 3863&#x2013;3869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8062941</ArticleId><ArticleId IdType="pubmed">33891272</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi J. Researchers investigate what COVID-19 does to the heart. JAMA 2021; 325: 808&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pubmed">33566089</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantha S, Tripuraneni SL, Roizen MF, et al.. Proposed modifications in the 6-minute walk test for potential application in patients with mild COVID-19: a step to optimize triage guidelines. Anesth Analg 2020; 131: 398&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258841</ArticleId><ArticleId IdType="pubmed">32433249</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS). Arthritis Care Res 2011; 63: S263&#x2013;S286.</Citation><ArticleIdList><ArticleId IdType="pubmed">22588750</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Ward CH, Mendelson M, et al.. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">13688369</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang L, Yang Y, Gao J. Cognitive assessment tools for mild cognitive impairment screening. J Neurol 2021; 268: 1615&#x2013;1622.</Citation><ArticleIdList><ArticleId IdType="pubmed">31414193</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991; 38: 143&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">1754629</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph T, Auger SD, Peress L, et al.. Screening performance of abbreviated versions of the UPSIT smell test. J Neurol 2019; 266: 1897&#x2013;1906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6647236</ArticleId><ArticleId IdType="pubmed">31053960</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon G, Barco S, et al.. The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J 2020; 56: 2001494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, Gavriatopoulou M, Hicklen RS, et al.. Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review. J Infect 2021; 83: 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al.. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26: 1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathi A, Jadhav SB, Shah N. A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of post-COVID fatigue. Medicines 2021; 8: 47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8472462</ArticleId><ArticleId IdType="pubmed">34564089</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahebnasagh A, Saghafi F, Avan R, et al.. The prophylaxis and treatment potential of supplements for COVID-19. Eur J Pharmacol 2020; 887: 173530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462519</ArticleId><ArticleId IdType="pubmed">32882216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D-Y, Lee J-S, Park S-Y, et al.. Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med 2020; 18: 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6943902</ArticleId><ArticleId IdType="pubmed">31906979</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Rekeland IG, Lien K, et al.. B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2019; 170: 585&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">30934066</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis G, Dos Santos Moreira-Silva EA, Silva DCM, et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health 2022; 10: e42&#x2013;e51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8550952</ArticleId><ArticleId IdType="pubmed">34717820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze EJ, Mattar C, Zorumski CF, et al.. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial. JAMA 2020; 324: 2292&#x2013;2300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7662481</ArticleId><ArticleId IdType="pubmed">33180097</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Zanardi R, Palladini M, et al.. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol 2021; 54: 1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500775</ArticleId><ArticleId IdType="pubmed">34634679</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullard A. Long COVID&#x2019;s long R&amp;D agenda. Nat Rev Drug Discov 2021; 20: 329&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">33879882</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID-19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res 2020; 32: 1613&#x2013;1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta A, Kalhan A, Kalra S. Long term complications and rehabilitation of COVID-19 patients. J Pak Med Assoc 2020; 70 S131&#x2013;S135.</Citation><ArticleIdList><ArticleId IdType="pubmed">32515393</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L, Zhu G. Psychological interventions for people affected by the COVID-19 epidemic. Lancet Psychiatry 2020; 7: 300&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128328</ArticleId><ArticleId IdType="pubmed">32085840</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisicaro F, Di Napoli M, Liberto A, et al.. Neurological sequelae in patients with COVID-19: a histopathological perspective. Int J Environ Res Public Health 2021; 18: 1415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7913756</ArticleId><ArticleId IdType="pubmed">33546463</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M, Go&#xeb;rtz YMJ, Houben-Wilke S, et al.. Severe fatigue in long COVID: follow-up study in members of online long COVID support groups. J Med Internet Res 2021; 23: e30274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8457337</ArticleId><ArticleId IdType="pubmed">34494964</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol 2011; 11: 37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med 2021; 21: e68&#x2013;e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>